Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Mandeep Smith, BSN, RN

Advertisement

Articles by Mandeep Smith, BSN, RN

Starting at "Zero" - Achieving Hospice and Palliative Care Certification

ByDawn Blake-Holmes, MSN, APRN, CCNS,Mandeep Smith, BSN, RN
September 22nd 2016

Leaders from Yale Smilow saw an opportunity to create an educational program to facilitate certification of inpatient and outpatient nurses in hospice and palliative care.

Advertisement

Latest Updated Articles

  • Starting at "Zero" - Achieving Hospice and Palliative Care Certification
    Starting at "Zero" - Achieving Hospice and Palliative Care Certification

    September 22nd 2016



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients

2

FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications

3

Personalizing Frontline ADC Selection in Metastatic Triple-Negative Breast Cancer

4

Frontline Sevabertinib Approved in HER2-Mutant NSCLC: Nursing Priorities

5

FDA Camizestrant Approval: Nurses Key to New Breast Cancer Paradigm

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us